HVA in healthcare most commonly stands for Hazard Vulnerability Analysis, a structured process hospitals use to identify which emergencies pose the greatest threat to their facility and surrounding community. The acronym also appears in clinical laboratory settings, where HVA refers to homovanillic acid, a substance measured in urine to help diagnose certain tumors in children. The meaning depends entirely on context, so here’s what you need to know about both.
HVA as Hazard Vulnerability Analysis
A Hazard Vulnerability Analysis is a systematic method for figuring out which disasters, emergencies, or disruptions are most likely to affect a healthcare facility and how severe the consequences would be. Hospitals, nursing homes, and other healthcare organizations use it to decide where to focus their emergency planning, training, and resources. Rather than preparing equally for every conceivable threat, an HVA helps leadership rank hazards so the biggest risks get the most attention.
The types of hazards evaluated typically fall into broad categories: natural events like hurricanes, earthquakes, and floods; technological failures like power outages or IT system crashes; human-caused threats like active shooters or cyberattacks; and hazardous material incidents. For each hazard, the analysis looks at three core dimensions: the probability that it will actually happen, the severity of its impact on patients, staff, and operations, and how well existing safeguards and preparedness measures reduce that risk.
Several standardized tools exist to help organizations run this analysis. The Kaiser Permanente HVA Tool is one of the most widely used. It takes input from a facility’s planning team on the probability and impact of each threat, then factors in what mitigation and preparedness steps are already in place to generate a risk score for each hazard. Other tools, like the Pennsylvania Public Health Risk Assessment Tool, measure severity across five domains including human health, healthcare services, and community public health infrastructure. The UCLA Hazard Risk Assessment Instrument breaks the process into four steps: estimating the probability of an incident, rating the severity of consequences, scoring those consequences, and performing a final risk analysis.
Why Hospitals Are Required to Do It
An HVA isn’t optional for accredited hospitals. The Joint Commission, which sets safety and quality standards for U.S. healthcare organizations, requires facilities to conduct one as part of their emergency management program. The standard (EM.11.01.01) expects organizations to identify potential emergencies affecting both the facility itself and the surrounding community. The completed HVA must be documented and reviewed at least every two years. It should also be updated whenever an after-action report from a real emergency or a drill reveals gaps or new risks that weren’t previously considered.
This requirement exists because healthcare facilities face a unique problem during emergencies: demand for their services surges at the exact moment their ability to deliver those services may be compromised. A flood might knock out a hospital’s electrical systems while simultaneously sending dozens of injured people through the doors. An HVA forces organizations to think through these scenarios in advance, so they aren’t making critical decisions for the first time during a crisis.
What the Process Looks Like in Practice
Running an HVA is a team effort. Hospitals typically assemble a group that includes leaders from emergency management, facilities, nursing, administration, and sometimes representatives from the local public health department or emergency medical services. The group works through a list of potential hazards relevant to their geography and operations.
For each hazard, the team assigns scores for likelihood and impact. Impact scoring often considers multiple dimensions: how many people could be harmed, whether the facility would need to evacuate or shelter in place, how long normal operations would be disrupted, and what financial losses might result. The team then evaluates what protections are already in place, such as backup generators, mutual aid agreements with nearby hospitals, or stockpiled supplies. The final risk score reflects the gap between how bad things could get and how prepared the organization currently is.
The output is a prioritized list. Hazards at the top drive decisions about where to invest in equipment, which scenarios to practice during emergency drills, and what policies need to be written or revised. A coastal hospital might find hurricanes and storm surge at the top of its list, while an urban medical center might prioritize active shooter events and infrastructure failures.
HVA as Homovanillic Acid
In laboratory medicine, HVA stands for homovanillic acid, a byproduct the body creates when it breaks down dopamine, one of the brain’s key chemical messengers. Measuring HVA levels in urine is primarily used in pediatric oncology to screen for and monitor neuroblastoma, a cancer that develops from nerve tissue and is one of the most common solid tumors in young children.
Neuroblastoma and related tumors that arise from nerve cells often produce large amounts of dopamine-related chemicals, which the body then converts to HVA and excretes in urine. Elevated urinary HVA levels, along with another metabolite called VMA (vanillylmandelic acid), have historically been found in roughly 90 to 95 percent of neuroblastoma cases. In a population-based study spanning 40 years, clinically significant elevations of HVA or VMA were present at diagnosis in 71 percent of confirmed neuroblastoma cases. HVA was actually a slightly better marker than VMA in that study: HVA was elevated above twice the upper limit of normal in 71 percent of cases, compared to 57 percent for VMA alone.
The test is also useful for detecting rare genetic conditions that affect how the body processes dopamine. One such condition causes abnormally low HVA levels in urine, while another causes elevated levels because the body can’t convert dopamine to the next chemical in the pathway, leading to a buildup that gets shunted toward HVA instead.
How the Test Works
The standard test collects urine over a 24-hour period. Normal reference ranges depend on age. For adults 18 and older, a normal result is up to 15 mg per day, or up to 8 mg per gram of creatinine (a ratio that adjusts for how concentrated the urine is). Children have higher normal ranges relative to body size: up to 42 mg per gram of creatinine for children under 2, up to 22 for ages 3 to 5, and up to 15 for ages 6 to 17. These pediatric ranges matter because neuroblastoma screening happens almost exclusively in children, and using adult cutoffs would produce misleading results.
Beyond initial diagnosis, the test is used to monitor children who have already been treated for neuroblastoma. A rising HVA level after treatment can signal that the tumor has returned, making it a practical surveillance tool during follow-up care.